期刊
CANCER DISCOVERY
卷 7, 期 6, 页码 558-560出版社
AMER ASSOC CANCER RESEARCH
DOI: 10.1158/2159-8290.CD-17-0087
关键词
-
类别
资金
- National Medical Research Council (NMRC) research training fellowship, Singapore
- NIH [R01 CA187238]
- Academy of Medical Sciences
BRAF mutations in colorectal cancer portend a poor prognosis, with first-line treatment often involving triplet or quadruplet chemotherapy, and single-agent targeted therapy with BRAF inhibitors failing to demonstrate clinical activity. Blockade of multiple critical nodes along the MAPK and other pathways may be necessary to improve response rates and survival. (C) 2017 AACR.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据